Key Areas for Anheuser-Busch InBev Investors to Prioritize

By Chris Stiles • Wednesday, February 28 15:10 • Permanent Link

Join us for a quick overview of Anheuser-Busch InBev, a Beverages company whose shares moved -1.2% today. Here are some facts about the stock that should help you see the bigger picture:

Anheuser-Busch InBev has moved 4.7% over the last year, and the S&P 500 logged a change of 28.5%
BUD has an average analyst rating of buy and is -11.98% away from its mean target price of $70.81 per share
Its trailing earnings per share (EPS) is $3.07
Anheuser-Busch InBev has a trailing 12 month Price to Earnings (P/E) ratio of 20.3 while the S&P 500 average is 15.97
Its forward earnings per share (EPS) is $3.46 and its forward P/E ratio is 18.0
The company has a Price to Book (P/B) ratio of 1.6 in contrast to the S&P 500's average ratio of 2.95
Anheuser-Busch InBev is part of the Consumer Staples sector, which has an average P/E ratio of 21.21 and an average P/B of 4.12
BUD has reported YOY quarterly earnings growth of 2.5% and gross profit margins of 0.5%
Anheuser-Busch InBev SA/NV produces, distributes, markets, and sells beer and beverages. It offers a portfolio of approximately 500 beer brands, which primarily include Budweiser, Corona, and Stella Artois; Beck's, Hoegaarden, Leffe, and Michelob Ultra; and Aguila, Antarctica, Bud Light, Brahma, Cass, Castle, Castle Lite, Cristal, Harbin, Jupiler, Modelo Especial, Quilmes, Victoria, Sedrin, and Skol brands. The company was founded in 1366 and is headquartered in Leuven, Belgium.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.